SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,728.16 -281.09
( -0.36%)

Global Indices

Nasdaq

53,489.46 -263.95
(-0.49%)

Dow Jones

7,767.06 -39.70
(-0.51%)

Hang Seng

69,148.70 434.90
(0.63%)

Nikkei 225

10,727.81 -22.30
(-0.21%)

Forex

USD-INR

95.39 0.02
(0.02%)

EUR-INR

109.98 -0.03
(-0.03%)

GBP-INR

128.68 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Refex Industries Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

532884

INE056I01025

104.9485179

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REFEX

14.45

4157.75

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.33

Back

fredun pharmaceuticals ltd

Fredun Pharmaceuticals consolidated net profit rises 93.94% in the June 2026 quarter

Aug 05,2026

Net profit of Fredun Pharmaceuticals rose 93.94% to Rs 13.13 crore in the quarter ended June 2026 as against Rs 6.77 crore during the previous quarter ended June 2025. Sales rose 90.75% to Rs 227.76 crore in the quarter ended June 2026 as against Rs 119.40 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	227.76	119.40	91
OPM %	14.37	14.23	-
PBDT	24.12	10.46	131
PBT	20.55	9.04	127
NP	13.13	6.77	94

77,728.16 -281.09 ( -0.36%)

53,489.46 -263.95 (-0.49%)

7,767.06 -39.70 (-0.51%)

69,148.70 434.90 (0.63%)

10,727.81 -22.30 (-0.21%)

95.39 0.02 (0.02%)

109.98 -0.03 (-0.03%)

128.68 -0.13 (-0.10%)

0.60 0.00 (-0.03%)